Evidence map›Paper›PMID 40565764›Full record

ArticleJournal of clinical medicine2025

Sodium Oxybate (SMO) as Part of Agonist Opioid Treatment in Alcohol-Heroin-Addicted Patients.

Angelo G I Maremmani, Filippo Della Rocca, Matteo Pacini, Silvia Bacciardi, Silvia Cimino, Luca Cerniglia, Mario Miccoli, Icro Maremmani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angelo G I MaremmaniVP Dole Research Group, PISA-School of Addiction Medicine, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.ORCID 0000-0001-7728-3705
Filippo Della RoccaVP Dole Research Group, PISA-School of Addiction Medicine, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.ORCID 0000-0002-7935-3524
Matteo PaciniVP Dole Research Group, PISA-School of Addiction Medicine, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.
Silvia BacciardiVP Dole Research Group, PISA-School of Addiction Medicine, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.
Silvia CiminoDepartment of Clinical, Dynamic and Health Psychology, Sapienza University, 00185 Rome, Italy.
Luca CernigliaFaculty of Psychology, International Telematic University Uninettuno, 00186 Rome, Italy.ORCID 0000-0002-6115-288X
Mario MiccoliAddiction Research Methods Institute, World Federation for the Treatment of Opioid Dependence, 225 Varick Street, Suite 402, New York, NY 10014, USA.ORCID 0000-0002-8632-6145
Icro MaremmaniVP Dole Research Group, PISA-School of Addiction Medicine, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.ORCID 0000-0002-6324-0576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

agonist opioid treatmentalcohol use disorderefficacyheroin use disorderHUDlong-term treatmentOATretention in treatmentsafetySMOsodium oxybate

Identifiers

PMID40565764
PMCPMC12193578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.